GT201100186A - Compuestos etanaminicos y su uso para tratar la depresion - Google Patents

Compuestos etanaminicos y su uso para tratar la depresion

Info

Publication number
GT201100186A
GT201100186A GT201100186A GT201100186A GT201100186A GT 201100186 A GT201100186 A GT 201100186A GT 201100186 A GT201100186 A GT 201100186A GT 201100186 A GT201100186 A GT 201100186A GT 201100186 A GT201100186 A GT 201100186A
Authority
GT
Guatemala
Prior art keywords
ethanaminal
compounds
treat depression
piridin
amina
Prior art date
Application number
GT201100186A
Other languages
English (en)
Inventor
Balestra Michael
Bernstein Peter
Glen E Ernst
Frietze William
John P Mccauley
Nugiel David
Shen Lihong
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=42288011&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=GT201100186(A) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed filed Critical
Publication of GT201100186A publication Critical patent/GT201100186A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms
    • C07D213/38—Radicals substituted by singly-bound nitrogen atoms having only hydrogen or hydrocarbon radicals attached to the substituent nitrogen atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4402—Non condensed pyridines; Hydrogenated derivatives thereof only substituted in position 2, e.g. pheniramine, bisacodyl
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C57/00—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms
    • C07C57/02—Unsaturated compounds having carboxyl groups bound to acyclic carbon atoms with only carbon-to-carbon double bonds as unsaturation
    • C07C57/13—Dicarboxylic acids
    • C07C57/15—Fumaric acid
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
    • C07D213/36—Radicals substituted by singly-bound nitrogen atoms

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Epidemiology (AREA)
  • Pain & Pain Management (AREA)
  • Psychiatry (AREA)
  • Psychology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Confectionery (AREA)

Abstract

LA PRESENRTE INVENCIÓNSE REFIERE A COMPUESTOS ETANAMÍNICOS: 1-(3-FLUOROFENIL) -2- METIL-2- (PIRIDIN-2-IL) PROPAN-1-AMINA Y 2-METIL-1-FENIL-2 (PIRIDIN-2-IL) PROPAN-1-AMINA Y SUS SALES Y ENANTIÓMEROS Y SU USO PARA TRATAR DEPRESIÓN.
GT201100186A 2008-12-24 2011-06-24 Compuestos etanaminicos y su uso para tratar la depresion GT201100186A (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US14067308P 2008-12-24 2008-12-24

Publications (1)

Publication Number Publication Date
GT201100186A true GT201100186A (es) 2013-10-08

Family

ID=42288011

Family Applications (1)

Application Number Title Priority Date Filing Date
GT201100186A GT201100186A (es) 2008-12-24 2011-06-24 Compuestos etanaminicos y su uso para tratar la depresion

Country Status (31)

Country Link
US (4) US8013165B2 (es)
EP (2) EP2610246A1 (es)
JP (1) JP5491524B2 (es)
KR (1) KR20110097996A (es)
CN (1) CN102333762B (es)
AR (1) AR074981A1 (es)
AU (1) AU2009330745B2 (es)
BR (1) BRPI0923476A2 (es)
CA (1) CA2748235A1 (es)
CL (1) CL2011001590A1 (es)
CO (1) CO6450688A2 (es)
CR (1) CR20110365A (es)
CU (1) CU24017B1 (es)
DO (1) DOP2011000205A (es)
EA (1) EA201190064A1 (es)
EC (1) ECSP11011161A (es)
GT (1) GT201100186A (es)
HN (1) HN2011001773A (es)
IL (1) IL213518A0 (es)
MX (1) MX2011006680A (es)
NI (1) NI201100131A (es)
NZ (1) NZ593282A (es)
PE (1) PE20120249A1 (es)
SA (1) SA109310013B1 (es)
SG (2) SG171928A1 (es)
SV (1) SV2011003962A (es)
TW (1) TWI442922B (es)
UA (1) UA106056C2 (es)
UY (1) UY32360A (es)
WO (1) WO2010074647A1 (es)
ZA (1) ZA201105441B (es)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EA201190064A1 (ru) * 2008-12-24 2012-02-28 Астразенека Аб Соединения этанамина и их применение для лечения депрессии
CN112250676B (zh) * 2020-11-24 2023-05-16 深圳市第二人民医院(深圳市转化医学研究院) 一种具有抗抑郁活性的含氧杂环化合物
CN112279843B (zh) * 2020-11-24 2023-05-16 深圳市第二人民医院(深圳市转化医学研究院) 一种具有抗抑郁活性的含氮杂环化合物

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3422191A (en) * 1965-01-21 1969-01-14 Synergistics Inc Compositions and methods for tranquilization employing salts of n-morpholine ethanol
GB1427026A (en) 1972-11-20 1976-03-03 Ici Ltd Synthetic film materials
JPS5756474B2 (es) 1973-05-26 1982-11-30
GB9320273D0 (en) 1993-04-01 1993-11-17 Fisons Corp Compound useful in therapy
US5455259A (en) * 1987-02-06 1995-10-03 Fisons Corporation Compounds for the treatment of neurodegenerative disorders
ATE135206T1 (de) 1988-08-12 1996-03-15 Astra Ab Arylalkylamine und -amide mit krampflösender und nervenschützender wirkung
JP2514855B2 (ja) 1990-08-08 1996-07-10 キッセイ薬品工業株式会社 光学活性なアラニンアニリド誘導体の酸付加塩
US5206248A (en) * 1992-03-27 1993-04-27 Smith Richard A Method for reducing emotional lability
ATE188212T1 (de) 1991-10-30 2000-01-15 Astra Ab 2-pyrazinylethylamin-derivate und ihre verwendung als arzneimittel.
DK0633879T3 (da) * 1992-04-03 1998-09-28 Astra Ab Enantiomert 1-phenyl-2(2-pyridinyl) ethylamin til behandling af neurodegenerative sygdomme
DK0898566T3 (da) * 1996-04-19 2003-03-03 Akzo Nobel Nv Substituerede benzylaminer og anvendelse deraf til behandling af depression
DE69809827D1 (de) 1997-03-31 2003-01-16 Korea Res Inst Chem Tech Chinolinische Sulfid-Derivate als NMDA Rezeptor-Antagonisten und Verfahren zu ihrer Herstellung
TW544448B (en) 1997-07-11 2003-08-01 Novartis Ag Pyridine derivatives
SE9901077D0 (sv) 1999-03-23 1999-03-23 Astra Ab Novel use
SE9901340D0 (sv) * 1999-04-15 1999-04-15 Astra Pharma Prod Novel process
DE10334188B4 (de) * 2003-07-26 2007-07-05 Schwarz Pharma Ag Verwendung von Rotigotin zur Behandlung von Depressionen
EA201190064A1 (ru) * 2008-12-24 2012-02-28 Астразенека Аб Соединения этанамина и их применение для лечения депрессии

Also Published As

Publication number Publication date
EP2391606A1 (en) 2011-12-07
JP5491524B2 (ja) 2014-05-14
US20100179199A1 (en) 2010-07-15
US20120115913A1 (en) 2012-05-10
US9035065B2 (en) 2015-05-19
TWI442922B (zh) 2014-07-01
US20120277272A1 (en) 2012-11-01
EA201190064A1 (ru) 2012-02-28
CN102333762B (zh) 2014-06-11
NZ593282A (en) 2013-06-28
SG171928A1 (en) 2011-07-28
CO6450688A2 (es) 2012-05-31
AU2009330745A1 (en) 2011-08-04
CU20110141A7 (es) 2012-01-31
ZA201105441B (en) 2012-03-28
BRPI0923476A2 (pt) 2016-01-19
AU2009330745B2 (en) 2012-04-05
CR20110365A (es) 2011-08-09
TW201028149A (en) 2010-08-01
MX2011006680A (es) 2011-07-12
AR074981A1 (es) 2011-03-02
CN102333762A (zh) 2012-01-25
ECSP11011161A (es) 2011-07-29
SA109310013B1 (ar) 2013-07-28
SV2011003962A (es) 2012-01-06
SG192510A1 (en) 2013-08-30
UA106056C2 (uk) 2014-07-25
US8013165B2 (en) 2011-09-06
KR20110097996A (ko) 2011-08-31
EP2391606A4 (en) 2012-06-13
CL2011001590A1 (es) 2012-06-22
NI201100131A (es) 2012-03-19
WO2010074647A1 (en) 2010-07-01
JP2012513993A (ja) 2012-06-21
CU24017B1 (es) 2014-07-30
DOP2011000205A (es) 2011-07-15
IL213518A0 (en) 2011-07-31
CA2748235A1 (en) 2010-07-01
UY32360A (es) 2010-07-30
EP2610246A1 (en) 2013-07-03
US20130137731A1 (en) 2013-05-30
PE20120249A1 (es) 2012-04-19
HN2011001773A (es) 2014-08-18

Similar Documents

Publication Publication Date Title
CL2009001263S1 (es) Maquina de afeitar.
CL2009000064S1 (es) Mango para maquina de afeitar.
UY34161A (es) 3,5-diamino-6-cloro-n-(n-(4-(4-(2-(hexil(2,3,4,5,6-pentahidroxihexil)amino)etoxi)fenil)butil) carbamimidoil)pirazina-2-carboxamida, sus usos, y composiciones que la contienen
SV2010003593A (es) Nuevos herbicidas
DK2305325T3 (da) Reduceret tryk-pumpe som har regulerede trykegenskaber
CL2011000481S1 (es) Aplicador para cuidado oral.
GT201200280A (es) Procedimiento
IT1394472B1 (it) Tavolo per riunioni.
CL2009001380S1 (es) Mango de maquina de afeitar.
UY31688A1 (es) Plaguicidas
CL2009001363S1 (es) Pieza para maquina de afeitar.
CL2009001235A1 (es) Compuestos derivados 4-(3-alquilsulfinilbenzoil)pirazoles, composiciones herbicidas que los contine, procedimiento para reprimir plantas indeseadas, uso dichos compuestos y compuestos intermediarios.
CR11601A (es) Pirimidil ciclopentanos hidroxilados en forma de inhibidores de akt proteina quinasa
CR20110075A (es) Agentes antifúngicos
GT201100186A (es) Compuestos etanaminicos y su uso para tratar la depresion
UY32042A (es) Compuestos de 2-aminopirimidina como potentes inhibidores de hsp-90
CL2008001014A1 (es) Procedimiento para preparar comprimidos de dihidrocloruro de prampipexol.
UY32983A (es) Fungicidas de azolil benceno sustituido por heterobiciclos
ECSP066818A (es) Proceso para la preparacion de inhibidores de triptasa
SM200900014A (it) Piano di lavoro ottimizzato.
CL2008003535S1 (es) Suela para calzado.
CL2008000274S1 (es) Perfil.
CL2008000260S1 (es) Perfil.
CL2008000262S1 (es) Perfil.
CL2008000267S1 (es) Perfil.